Compass Therapeutics (CMPX) Capital Expenditures (2019 - 2026)
Compass Therapeutics (CMPX) reported Capital Expenditures of $82000.0 for Q1 2026, up 355.56% on a YoY basis from $18000.0 in Q1 2025, and up 1071.43% sequentially from $7000.0 in Q3 2025.
Compass Therapeutics (CMPX) Capital Expenditures (2019 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 8 years of Capital Expenditures data on file, last reported at $82000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 355.56% year-over-year to $82000.0; the trailing twelve-month figure through Mar 2026 stood at $89000.0 (up 43.55% YoY), and the FY2025 full-year result was $25000.0, down 43.18% from the prior year.
- Capital Expenditures rose to $82000.0 in Q1 2026, from $7000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $194000.0 in Q1 2022 to a low of -$117000.0 in Q2 2022.
- A 5-year average of $35727.3 and a median of $18000.0 in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures sank 89.76% in 2022 and jumped 355.56% in 2026, its largest moves.
- Tracing CMPX's Capital Expenditures over 5 years: stood at $54000.0 in 2022, then sank by 83.33% to $9000.0 in 2023, then surged by 388.89% to $44000.0 in 2024, then plunged by 84.09% to $7000.0 in 2025, then jumped by 1071.43% to $82000.0 in 2026.
- Business Quant data shows CMPX's Capital Expenditures at $82000.0 in Q1 2026, $7000.0 in Q3 2025, and $18000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Compass Therapeutics | 395.17 Mn | 200.48 Mn | - | 82,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82,000.00 |
| Mar 31, 2026 | 82,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Sep 30, 2022 | 81,000.00 |
| Sep 30, 2022 | 81,000.00 |
| Jun 30, 2022 | -117,000.00 |
| Jun 30, 2022 | -117,000.00 |